(Q34016435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

António M F Arúajo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jose C Mendez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ana L Coelho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fernando Barata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ana Figueiredo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Teresina Amaro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Isabel Azevedo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Marta Soares

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

391-396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Aspirin and colon cancer--targeting prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Inhibition of cyclooxygenase: a novel approach to cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Celecoxib: a novel treatment for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

COX-2 inhibitors in cancer treatment and prevention, a recent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Intracellular unesterified arachidonic acid signals apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Coxibs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802232756

10.1080/07357900802232756

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266367%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference